Skip to main content
. 2016 May 20;12(2):1232–1242. doi: 10.3892/etm.2016.3377

Table IV.

Comparison of the statistical differences between the pre- and post-treatment measurements of various parameters among the three groups.

Parameter Control 10DF 20DF P1 P2 P3 P4
Weight (kg) −2.30±4.92 −1.76±4.20 −1.47±7.02 0.659 0.865 0.496 0.391
BMI (kg/m2) −0.82±1.84 −0.65±1.62 −0.58±2.72 0.877 0.901 0.720 0.622
Waist circumference (cm) −0.57±5.10 −2.54±5.69 0.09±6.44a 0.051 0.095 0.493 0.018
Hip circumference (cm) −1.86±4.78 −2.46±4.87 −0.21±5.09a 0.074 0.428 0.150 0.025
Waist/hip ratio 0.01±0.05 0.00±0.05 0.00±0.06 0.738 0.444 0.781 0.625
Systolic pressure (mmHg) −4.59±15.71 −4.93±15.83 −4.75±13.46 0.833 0.546 0.747 0.772
Diastolic pressure (mmHg) −0.51±8.34 −3.18±10.60 −0.78±9.48 0.399 0.405 0.639 0.181
Fasting blood glucose (mmol/l) −0.45±2.36 −1.00±2.36 −2.58±2.74b,c <0.001 0.303 <0.001 0.004
2 h blood glucose (mmol/l) −1.29±2.94 −2.77±3.97d −4.46±3.65a,b <0.001 0.033 <0.001 0.016
Fasting insulin (mU/l) −2.11±4.71 −2.04±5.43 −2.04±4.58 0.941 0.937 0.803 0.738
2 h insulin (mU/l) −3.07±7.62 −5.22±9.61 −4.69±6.31 0.514 0.250 0.519 0.605
HOMA-IR −0.79±1.26 −1.11±2.20 −1.80±2.44d 0.081 0.344 0.026 0.186
Fasting C-peptide (ng/ml) −0.32±1.05 −0.85±1.37 −0.62±1.23 0.684 0.386 0.690 0.627
2 h C-peptide (ng/ml) −1.00±3.04 −1.99±4.22 −0.88±2.97 0.127 0.989 0.085 0.076
Glycated albumin (%) −1.23±4.03 −4.73±4.06 −8.75±5.39b,c <0.001 <0.001 <0.001 <0.001
Cholesterol (mmol/l) −0.01±1.80 0.10±0.76 −0.93±1.32 0.848 0.570 0.723 0.828
Triglyceride (mmol/l) 0.37±2.19 −0.91±1.98 −0.84±1.69b 0.008 0.008 0.005 0.861
HDL (mmol/l) 0.10±0.41 0.09±0.30 0.24±0.65 0.251 0.818 0.129 0.187
LDL (mmol/l) −0.16±2.15 −0.13±0.61 −0.58±0.79d 0.091 0.195 0.030 0.368
Lpa (mg/l) −86.19±124.52 −60.00±147.05 −49.45±100.06 0.436 0.368 0.210 0.717
ApoA (g/l) −0.07±0.22 −0.06±0.30d −0.09±0.47d 0.028 0.021 0.018 0.922
ApoB (g/l) −0.07±0.24 −0.14±0.57 −0.34±0.59 0.609 0.344 0.776 0.506
Urea nitrogen (mmol/l) −0.60±3.34 −0.41±1.75 −0.41±1.79 0.921 0.692 0.781 0.904
Creatinine (µmol/l) −1.94±17.60 2.32±10.34 1.64±11.07 0.527 0.291 0.371 0.868
Uric acid (µmol/l) 3.92±77.67 −10.70±65.16 1.43±79.87 0.802 0.599 0.943 0.541

Data are presented as the mean ± standard deviation. Significant P-values (P<0.05) are indicated in bold.

a

P<0.05 vs. the 10DF group

b

P<0.01 vs. the control group

c

P<0.01 vs. the 10DF group

d

P<0.05 vs. the control group. P1, analysis of variance among the three groups; P2, comparison between the 10DF and control groups; P3, comparison between the 20DF and control groups; P4, comparison between the 10DF and 20DF groups; 10DF, 10 g/day dietary fiber; 20DG, 20 g/day dietary fiber; BMI, body mass index; HOMA-IR, homeostatic model assessment-insulin resistance; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Lpa, lipoprotein(a); Apo, apolipoprotein.